The Pennant Group (PNTG)
(Delayed Data from NSDQ)
$34.79 USD
+1.00 (2.96%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $34.78 -0.01 (-0.03%) 6:36 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.79 USD
+1.00 (2.96%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $34.78 -0.01 (-0.03%) 6:36 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
Zacks News
Encompass Health (EHC) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 11.69% and 0.99%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
The Pennant Group, Inc. (PNTG) Soars 5.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Should Value Investors Buy Encompass Health (EHC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's What Key Metrics Tell Us About The Pennant Group, Inc. (PNTG) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for The Pennant Group, Inc. (PNTG) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 12.50% and 5%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Encompass Health (EHC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 28.38% and 2.02%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Chemed (CHE) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Chemed (CHE) delivered earnings and revenue surprises of -7.47% and 1.30%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
The Pennant Group, Inc. (PNTG) Misses Q1 Earnings Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of -13.33% and 3.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Take the Zacks Approach to Beat the Market: Microsoft, Novo Nordisk, General Mills in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
New Strong Buy Stocks for April 17th
by Zacks Equity Research
IOT, PNTG, ACLX, ELUXY and AB have been added to the Zacks Rank #1 (Strong Buy) List on April 17, 2023.
Why Fast-paced Mover The Pennant Group, Inc. (PNTG) Is a Great Choice for Value Investors
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
PNTG vs. CHE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PNTG vs. CHE: Which Stock Is the Better Value Option?
3 Medical Device Stocks With Potential to Fight Recession Risk
by Indrajit Bandyopadhyay
Increasing interest rates, higher costs and rising unemployment paint an unfavorable picture with the risk of a recession looming large. Here we discuss three medical stocks that may be good bets even in a recession.
HCA Healthcare (HCA) Expands in Kansas With a Medical Plaza
by Zacks Equity Research
HCA Midwest, run by HCA Healthcare (HCA), plans to add a two-story medical plaza in Overland Park of $12 million, to be occupied by Family Health Medical Group and Town Plaza Women's Care.
Zacks Industry Outlook Highlights Chemed, Addus HomeCare, RadNet and The Pennant Group
by Zacks Equity Research
Chemed, Addus HomeCare, RadNet and The Pennant Group are part of the Zacks Industry Outlook article.
4 Promising Stocks From a Challenging Outpatient Home Health Industry
by Debanjana Dey
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.
Select Medical (SEM) Forays Into Indiana With Lutheran Health JV
by Zacks Equity Research
Select Medical (SEM) partners with Lutheran Health Network to enhance critical illness recovery and inpatient rehabilitation services in Fort Wayne and neighborhood communities.
PNTG or CHE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PNTG vs. CHE: Which Stock Is the Better Value Option?
Ensign Group's (ENSG) Buyout Consolidates Colorado Presence
by Zacks Equity Research
The Ensign Group (ENSG) buys two skilled nursing facilities in Colorado, aiming to expand its portfolio of nursing homes in the state.
Despite Fast-paced Momentum, The Pennant Group, Inc. (PNTG) Is Still a Bargain Stock
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
PNTG vs. CHE: Which Stock Is the Better Value Option?
by Zacks Equity Research
PNTG vs. CHE: Which Stock Is the Better Value Option?
The Pennant Group, Inc. (PNTG) Matches Q4 Earnings Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 0% and 6.01%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Encompass Health (EHC) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 3.53% and 1.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Option Care Health, LifeStance Health, Addus HomeCare and Pennant
by Zacks Equity Research
Option Care Health, LifeStance Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.
4 Stocks to Watch Amid a Challenging Outpatient Home Health Industry
by Zacks Equity Research
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. OPCH, LFST, ADUS and PNTG are well poised to gain from the prospects.